Innovation, performance, value keys to foot care

The foot care category is still dominated by Bayer Consumer’s Dr Scholl’s, which generated $291.9 million in sales for the 52 weeks ended June 4, on a 6.8% decline, according to Nielsen data as provided by Implus. Store brands gained 7.4% in that time frame to $65.6 million, and Implus gained 47.5% with the Airplus brand to $40.7 million.

(To view the full ECRM Report, click here.)



“The foot care consumer is still looking for products that work,” Steve Head, Implus EVP sales, told Drug Store News. “Our focus on innovation and performance while keeping a keen eye on value has been the key to our success,” he said. “With five new items launching in 2017, we are confident that we can continue to help consumers with their foot needs and retailers drive sales.”